A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema

PHASE4WithdrawnINTERVENTIONAL

Timeline

Start Date

January 1, 2024

Primary Completion Date

April 26, 2027

Study Completion Date

May 7, 2029

Conditions

Chronic Obstructive Pulmonary Disease (COPD)Alpha1-Antitrypsin Deficiency

Interventions

BIOLOGICAL

RYMPHYSIA

RYMPHYSIA administered through an IV injection.

BIOLOGICAL

Another Available A1PI

Another available A1PI administered through an IV injection.